Top

Published in:

01-03-2016 | Minimally Invasive Surgery (T Guzzo, Section Editor)

Contemporary Status of Percutaneous Ablation for the Small Renal Mass

Authors: Benjamin J. Shin, Jeffrey Forris Beecham Chick, S. William Stavropoulos

Published in: Current Urology Reports | Issue 3/2016

Abstract

Renal cell carcinoma is the tenth most common malignancy in the USA, with upwards of 61,000 new cases and resulting in more than 14,000 deaths annually. Although partial nephrectomy remains the standard treatment, image-guided nephron-sparing ablative techniques including cryoablation, radiofrequency ablation, and microwave ablation have emerged as treatment options in certain patient populations. Ablative therapies have high technical successes, low tumor recurrence rates, and preserve renal parenchymal volume. The purpose of this article is to provide an update on ablation therapies for small renal masses.

Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373(9669):1119–32. doi:S0140-6736(09)60229-4 [pii]10.1016/S0140-6736(09)60229-4

Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353(23)):2477. doi:10.1056/NEJMra043172.CrossRefPubMed

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69. doi:10.3322/caac.20107.CrossRefPubMed

Sahni VA, Silverman SG. Imaging management of incidentally detected small renal masses. Semin Intervent Radiol. 2014;31(1):9. doi:10.1055/s-0033-136383800813.PubMedCentralCrossRefPubMed

Finley DS, Pantuck AJ, Belldegrun AS. Tumor biology and prognostic factors in renal cell carcinoma. Oncologist. 2011;16(2):4. doi:10.1634/theoncologist.2011-S2-04.PubMedCentralCrossRefPubMed

Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797.PubMedCentralCrossRefPubMed

Bakal CW, Cynamon J, Lakritz PS, Sprayregen S. Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Interv Radiol. 1993;4(6):727.CrossRefPubMed

Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182((4):1271. doi:10.1016/j.juro.2009.07.004.CrossRef

Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913. doi:10.1016/j.eururo.2015.01.005.CrossRefPubMed

10.

Van Poppel H, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MA, et al. Treatment of localised renal cell carcinoma. Eur Urol. 2011;60(4):662. doi:10.1016/j.eururo.2011.06.040.CrossRefPubMed

11.

Trudeau V, Larcher A, Boehm K, Dell'Oglio P, Sun M, Tian Z. Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: a Population-Based Study. Urology. 2015. doi:10.1016/j.urology.2015.08.043.PubMed

12.

Ogan K, Jacomides L, Dolmatch BL, Rivera FJ, Dellaria MF, Josephs SC, et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology. 2002;60(6):954.CrossRefPubMed

13.

Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo V. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(3:ii):49. doi:10.1093/annonc/mdu259.CrossRef

14.••

Tuncali K, van Sonnenberg E, Shankar S, Mortele KJ, Cibas ES, Silverman SG. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. AJR Am J Roentgenol. 2004;18(3):575. doi:10.2214/ajr.183.3.1830575. A study that highlights the importance of biopsy prior to ablation procedures.CrossRef

15.

Schmit GD, Kurup AN, Weisbrod AJ, Thompson RH, Boorjian SA, Wass CT, et al. ABLATE: a renal ablation planning algorithm. AJR Am J Roentgenol. 2014;202(4):894. doi:10.2214/AJR.13.11110.CrossRefPubMed

16.

Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844. doi:10.1016/j.juro.2009.05.035.CrossRefPubMed

17.•

Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Boorjian SA, Carter RE. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. J Urol. 2013;89(1):30. doi:10.1016/j.juro.2012.08.180. A study that introduces the RENAL nephrometry algorithm to predict the outcomes and complications associated with ablation procedures.CrossRef

18.

Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics. 2010;30(4):887. doi:10.1148/rg.304095134.CrossRefPubMed

19.

Sahni VA, Silverman SG. Biopsy of renal masses: when and why. Cancer Imaging. 2009;9:44. doi:10.1102/1470-7330.2009.0005.PubMedCentralCrossRefPubMed

20.

Ramanathan R, Leveillee RJ. Ablative therapies for renal tumors. Ther Adv Urol. 2010;2(2):51. doi:10.1177/175628721036670810.1177_1756287210366708.PubMedCentralCrossRefPubMed

21.

Venkatesan AM, Wood BJ, Gervais DA. Percutaneous ablation in the kidney. . 2011;26(2):375. doi:10.1148/radiol.11091207.

22.

Dominguez-Escrig JL, Sahadevan K, Johnson P. Cryoablation for small renal masses. Adv Urol. 2008:479495. doi:10.1155/2008/479495

23.

Zagoria RJ. Imaging-guided radiofrequency ablation of renal masses. Radiographics. 2004;24(1):S59. doi:10.1148/rg.24si045512.CrossRefPubMed

24.

Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25(1):S69. doi:10.1148/rg.25si055501.CrossRefPubMed

25.

Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology. 2012;263:900. doi:10.1148/radiol.12111209.CrossRefPubMed

26.

Weizer AZ, Raj GV, O'Connell M, Robertson CN, Nelson RC, Polascik TJ. Complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005;66(6):1176. doi:10.1016/j.urology.2005.06.125.CrossRefPubMed

27.

Kurup AN. Percutaneous ablation for small renal masses-complications. Semin Intervent Radiol. 2014;31(1):42. doi:10.1055/s-0033-136384200817.PubMedCentralCrossRefPubMed

28.

Bhayani SB, Allaf ME, Su LM, Solomon SB. Neuromuscular complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005;65(3):592. doi:10.1016/j.urology.2004.09.053.CrossRefPubMed

29.

Higgins LJ, Hong K. Renal ablation techniques: state of the art. AJR Am J Roentgenol. 2015;205(4):735. doi:10.2214/AJR.15.14752.CrossRefPubMed

30.

Siu W, Hafez KS, 3rd Johnston WK, Jr. Wolf JS. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol. 2007;25(2):115. doi:10.1016/j.urolonc.2006.07.018.CrossRefPubMed

31.

Iannuccilli JD, Grand DJ, Dupuy DE, Mayo-Smith WW. Percutaneous ablation for small renal masses-imaging follow-up. Semin Intervent Radiol. 2014;31(1):50. doi:10.1055/s-0033-136384300818.PubMedCentralCrossRefPubMed

32.

Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int. 2007;100(2):287. doi:10.1111/j.1464-410X.2007.06937.x.CrossRefPubMed

33.

Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA, et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol. 2012;61(6):1156. doi:10.1016/j.eururo.2012.01.001.CrossRefPubMed

34.

Chang X, Zhang F, Liu T, Ji C, Zhao X, Yang R. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes. J Urol. 2015;193(2):430. doi:10.1016/j.juro.2014.07.112.CrossRefPubMed

35.••

Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67(2):252–9. doi:10.1016/j.eururo.2014.07.021. A study comparing partial nephrectomy to both radiofrequency and cryoablation ablation for cT1 renal masses.CrossRefPubMed

36.

Klatte T, Grubmuller B, Waldert M, Weibl P, Remzi M. Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol. 2011;60(3):435. doi:10.1016/j.eururo.2011.05.002.CrossRefPubMed

37.

Aron M, Kamoi K, Remer E, Berger A, Desai M, Gill I, et al. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol. 2010;183(3):889. doi:10.1016/j.juro.2009.11.041.CrossRefPubMed

38.•

Zargar H, Samarasekera D, Khalifeh A, Remer EM, O'Malley C, Akca O. Laparoscopic vs percutaneous cryoablation for the small renal mass: 15-year experience at a single center. Urology. 2015;85(4):850. doi:10.1016/j.urology.2015.01.004. A study comparing laparoscopic and cryoablation for small renal masses showing no difference between overall or recurrence-free survival.CrossRefPubMed

39.

Goyal J, Verma P, Sidana A, Georgiades CS, Rodriguez R. Single-center comparative oncologic outcomes of surgical and percutaneous cryoablation for treatment of renal tumors. J Endourol. 2012;26(11):1413. doi:10.1089/end.2012.0244.CrossRefPubMed

40.

Moreland AJ, Ziemlewicz TJ, Best SL, Hinshaw JL, Lubner MG, Alexander ML, et al. High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation. J Endourol. 2014;28(9):1046. doi:10.1089/end.2014.0190.CrossRefPubMed

41.•

Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Zhang X. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results. Radiology. 2014;270(3):880. doi:10.1148/radiol.13130275. A study comparing radical nephrectomy and microwave ablation showing comparable oncologic results for nephrectomy and microwave ablation and no major complications for microwave ablation.CrossRefPubMed

42.

Guan W, Bai J, Liu J, Wang S, Zhuang Q, Ye Z, et al. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol. 2012;106(3):316. doi:10.1002/jso.23071.CrossRefPubMed

Title: Contemporary Status of Percutaneous Ablation for the Small Renal Mass
Authors: Benjamin J. Shin
Jeffrey Forris Beecham Chick
S. William Stavropoulos
Publication date: 01-03-2016
Publisher: Springer US
Published in: Current Urology Reports / Issue 3/2016
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-016-0581-7

At a glance: The STEP trials

Springer Medicine

Contemporary Status of Percutaneous Ablation for the Small Renal Mass

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

Prostate Cancer Imaging with Novel PET Tracers

Underactive Bladder

Rectourethral Fistula Management

Novel Technologies in Urologic Surgery: a Rapidly Changing Scenario

The Utility of Molecular Imaging in Prostate Cancer

Pelvic Prolapse Repair in the Era of Mesh